Mahamaya lifesciences Limited has been recognized with a prestigious industry award, marking a significant achievement for the pharmaceutical company. The company received the 'Company of the Year – Medium Scale' award at the International Crop Science Conference & Exhibition (ICSCE) 2026 held in Dubai, demonstrating its excellence in the medium-scale pharmaceutical sector.

Award Recognition Details

The award was presented on January 20, 2026, as part of the PMFAI SML Awards 2026. The recognition comes from the Pesticides Manufacturers & Formulators Association of India (PMFAI), a leading industry body that acknowledges outstanding performance and contributions in the sector.

Regulatory Compliance

Mahamaya Lifesciences Limited disclosed this achievement through a formal communication to the Bombay Stock Exchange Limited on January 22, 2026. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically under Part B of Schedule III, which covers events that require disclosure based on materiality guidelines.

The company's Managing Director, Krishnamurthy Ganesan (DIN: 00270539), signed the disclosure document, ensuring compliance with regulatory requirements. The company trades on BSE with scrip code 544611.

Company Profile

Mahamaya Lifesciences Limited, formerly known as Mahamaya Lifesciences Pvt. Ltd., operates as an ISO 9001:2015 certified company. The organization is headquartered at Spaze ITech Park in Gurugram, Haryana, and maintains its corporate identity number as U24233DL2002PLC115261.

This recognition at ICSCE 2026 reflects the company's commitment to excellence in the pharmaceutical and lifesciences sector, positioning it among the leading medium-scale companies in the industry.

Prominent investor Vijay Kedia has acquired a substantial stake in Mahamaya Lifesciences , purchasing 8.91 lakh shares at ₹140 per share. This investment represents a significant vote of confidence in the SME-listed company operating in the agro chemicals sector.

Investment Details

The transaction details showcase the scale of Kedia's investment in the company:

Company Profile

Mahamaya Lifesciences operates in the agro chemicals sector and is classified as a small-cap company. The company is listed on the SME platform, which caters to small and medium enterprises seeking capital market access. The agro chemicals sector has been witnessing increased investor attention due to its growth potential and essential role in agricultural productivity.

Market Significance

Vijay Kedia's investment in Mahamaya Lifesciences adds to his diverse portfolio of equity investments. Known for his stock-picking abilities and long-term investment approach, Kedia's stake acquisition often draws market attention. His investment decisions are closely watched by retail and institutional investors alike, given his track record in identifying potential growth stories.

The acquisition at ₹140 per share indicates Kedia's confidence in the company's business prospects and growth trajectory in the agro chemicals space.